Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Article uri icon

Overview

authors

publication date

  • September 1, 2025

Identity

PubMed Central ID

  • PMC12443589

Scopus Document Identifier

  • 105011276127

Digital Object Identifier (DOI)

  • 10.1038/s41591-025-03895-1

PubMed ID

  • 40691367

Additional Document Info

volume

  • 31

issue

  • 9